Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
RESEARCH TOOLSreports
AN2 Therapeutics, Inc. (ANTX) Ownership - Who Owns AN2 Therapeutics, Inc.?
72 Followers
AN2 Therapeutics, Inc. (ANTX) Ownership Overview
43.03% Insiders
5.45% Mutual Funds
47.03% Other Institutional Investors
4.49% Public Companies and
Individual Investors
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail and individual investors. Approximately 52.48% of the company’s stock is owned by Institutional Investors, 43.03% is owned by Insiders and 4.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 19, 2024 | Joseph Zakrzewski Director | xxxxxxxxxxxxx | $1911000 |
| Jan 18, 2024 | Adjuvant Global Health Technology Fund, L.p. >10% Owner | xxxxxxxxxxxxx | $1965000 |
| Jan 18, 2024 | Kabeer Aziz Director | xxxxxxxxxxxxx | $1965000 |
| Aug 25, 2023 | Adjuvant Global Health Technology Fund, L.p. >10% Owner | xxxxxxxxxxxxx | $6400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,551,295 | Institution | 18.61% | 15,488,113 | |
| 1,011,352 | Institution | 3.39% | 2,821,672 | |
| 1,011,352 | Institution | 3.39% | 2,821,672 | |
| 163,156 | Institution | 0.55% | 455,205 | |
| 139,892 | Institution | 0.47% | 390,299 | |
| 95,944 | Institution | 0.32% | 267,684 | |
| 40,060 | Institution | 0.13% | 111,767 | |
| 34,967 | Institution | 0.12% | 97,558 | |
| 34,110 | Institution | 0.11% | 95,167 | |
| 33,448 | Institution | 0.11% | 93,320 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,011,352 | Institution | 3.39% | 2,821,672 | |
| 163,156 | Institution | 0.55% | 455,205 | |
| 139,892 | Institution | 0.47% | 390,299 | |
| 95,944 | Institution | 0.32% | 267,684 | |
| 40,060 | Institution | 0.13% | 111,767 | |
| 34,110 | Institution | 0.11% | 95,167 | |
| 33,448 | Institution | 0.11% | 93,320 | |
| 23,792 | Institution | 0.08% | 66,380 | |
| 17,261 | Institution | 0.06% | 48,158 | |
| 15,065 | Institution | 0.05% | 42,031 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 749,421 | Institution | 2.51% | 1,611,255 | |
| 261,931 | Institution | 0.88% | 563,152 | |
| 34,967 | Institution | 0.12% | 97,558 | |
| 19,620 | Institution | 0.07% | 55,917 | |
| 6,614 | Institution | 0.02% | 18,850 |
FAQ
Who Owns AN2 Therapeutics, Inc. (ANTX)?
According to the latest TipRanks data, approximately 47.03% of the company's stock is held by institutional investors, 43.03% is held by insiders, and 4.49% is held by retail investors.
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.03% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.49% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.
Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?
Peter Kolchinsky owns the most shares of AN2 Therapeutics, Inc. (ANTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.